With offices in Australia, Singapore, Thailand, Malaysia, Indonesia, Hong Kong and China, and a combined team of over 400 people, Spruson & Ferguson is one of the only specialist intellectual property firms with true regional capability, knowledge and experience. Each country serviced by Spruson & Ferguson is governed by a unique set of intellectual property laws, and in some cases, may have few to no laws in relation to intellectual property. Our specialist teams are highly familiar with the local IP laws of each country we service and are able to assist clients with IP protection, management and enforcement within each jurisdiction.

Southeast Asia
With offices in Singapore, Bangkok, Jakarta and Kuala Lumpur. Spruson & Ferguson are specialists in providing intellectual property services across Southeast Asia.
Learn More
China & East Asia
With offices in Beijing and Hong Kong. Spruson & Ferguson are specialists in providing intellectual property services across China & East Asia.
Learn More
Australasia
With offices in Sydney, Melbourne and Brisbane, Spruson & Ferguson are specialists in providing intellectual property services across Australasia.
Learn More

Overview & Recognition

500+
Employees
130+
Years
190+
IP Professionals
10
Offices
25+
Countries Serviced

Best Law Firms – Australia 2025

Best Lawyer

IP Boutique of the Year 2023-2025

Managing IP Asia Pacific Awards

WTR 1000 – Gold TM Prosecution & Strategy

World Trademark Review

MIP IP Stars – Tier 1 Patent Prosecution 2023-2025

Managing IP

IAM Patent 1000 – Gold 2024

IAM

Tier 1 – Sydney Region 2024

Doyle’s Guide

We have the regional capability to service our clients in over 25 jurisdictions across 10 offices in the Asia-Pacific.

China & East Asia

Southeast Asia

Australasia

Latest News & Insights
GREATER CHINA
China | Market Exclusivity and Data Exclusivity included in Drug Administration Law revisions
Marking a milestone in China’s drug regulatory landscape, the 2026 Revisions of China’s Drug Administration Law introduce data exclusivity and market exclusivity into the regulatory framework, establishing a multi‑dimensional…
Marking a milestone in China’s drug regulatory landscape, the 2026 Revisions of China’s Drug Administration Law introduce data exclusivity…
Read More
GREATER CHINA
China | Revised Anti-Unfair Competition Law expands Acts of Confusion (2025)  
Recent changes to China’s Anti-Unfair Competition Law reshape how businesses can use trade names, branding and search keywords. Practices that are commonly used in digital marketing now carry clearer…
Recent changes to China’s Anti-Unfair Competition Law reshape how businesses can use trade names, branding and search keywords. Practices…
Read More
View All

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe